Looking for leads, investment insights, or competitive intelligence?
News about AbbVie
AbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endometriosis.
The new cure could be a boon to poorer nations.
AbbVie and Alector hope to apply immunotherapy to dementia and Alzheimer's.
Stocks are flourishing and IPOs abound.
AbbVie's victory is bad news for rival biotech giant Gilead.